Low molecular weight heparin loaded pH-sensitive microparticles

International Journal of Pharmaceutics

Volumn 335, Issue 1-2, 2007, Pages 147-153

  Meissner, Yvette ^a   Ubrich, Nathalie ^a   Ghazouani, Fatima El ^a   Maincent, Philippe ^a   Lamprecht, Alf ^b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Double emulsion; Low molecular weight heparin; Microparticles; Oil water; Oral delivery; pH sensitive

Indexed keywords

CETRIMIDE; ENOXAPARIN; EUDRAGIT; LOW MOLECULAR WEIGHT HEPARIN; MICROSPHERE; OIL; P 4125F; POLYSORBATE 80; SORBITAN STEARATE; SURFACTANT; UNCLASSIFIED DRUG; WATER;

ARTICLE; COLON; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; ENCAPSULATION; ENTERITIS; EVAPORATION; IN VITRO STUDY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SOLVENT EXTRACTION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; CETRIMONIUM COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; ENOXAPARIN; GASTROINTESTINAL AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HEXOSES; HYDROGEN-ION CONCENTRATION; KINETICS; METHACRYLATES; MICROSPHERES; OILS; PARTICLE SIZE; POLYMERS; SOLUBILITY; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 33947723579     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.11.014     Document Type: Article

References (21)

1. Chourasia M.K., and Jain S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 6 (2003) 33-66
2. Cui H.F., and Jiang X.L. Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin. World J. Gastroenterol. 5 (1999) 448-450
3. Davis S.S., Hardy J.G., and Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut 27 (1986) 886-892
4. Dotan I., Hershkoviz R., Karmeli F., Brazowski E., Peled Y., Rachmilewitz D., and Halpern Z. Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats. Aliment Pharmacol. Ther. 15 (2001) 1687-1697
5. Hardy J.G., Wilson C.G., and Wood E. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 37 (1985) 874-877
6. Hoffart V., Ubrich N., Lamprecht A., Bachelier K., Vigneron C., Lecompte T., Hoffman M., and Maincent P. Microencapsulation of low molecular weight heparin into polymeric particles designed with biodegradable and nonbiodegradable polycationic polymers. Drug Deliv. 10 (2003) 1-7
7. Jeong Y.I., Prasad Y.R., Ohno T., Yoshikawa Y., Shibata N., Kato S., Takeuchi K., and Takada K. Application of Eudragit P-4135F for the delivery of ellagic acid to the rat lower small intestine. J. Pharm. Pharmacol. 53 (2001) 1079-1085
8. Jiao Y., Ubrich N., Hoffart V., Marchand-Arvier M., Vigneron C., Hoffman M., and Maincent P. Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits. J. Pharm. Sci. 91 (2002) 760-768
9. Lamprecht A., and Kawashima Y. pH-sensitive microparticles for oral drug delivery. J. Drug Del. Sci. Technol. 16 (2006) 26-34
10. Lamprecht A., Koenig P., Ubrich N., Maincent P., and Neumann D. Low molecular weight heparin nanoparticles: Mucoadhesion and behavior in Caco-2 cells. Nanotechnology 17 (2006) 3673-3680
11. Lamprecht A., Yamamoto H., Takeuchi H., and Kawashima Y. pH-sensitive microsphere delivery increases oral bioavailability of calcitonin. J. Contr. Rel. 98 (2004) 1-9
12. Lamprecht A., Yamamoto H., Ubrich N., Takeuchi H., Maincent P., and Kawashima Y. FK506 microparticles mitigate experimental colitis with minor renal calcineurin suppression. Pharm. Res. 22 (2005) 193-199
13. Lamprecht A., Yamamoto H., Takeuchi H., and Kawashima Y. Microsphere design for the colonic delivery of 5-fluorouracil. J. Contr. Rel. 90 (2003) 313-322
14. Nihant N., Schugens C., Grandfils C., Jerome R., and Teyssie P. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability. Pharm. Res. 11 (1994) 1479-1484
15. Okubo T., and Kobayashi K. Surface tension of biological polyelectrolyte solutions. J. Colloid Interf. Sci. 205 (1998) 433-442
16. Rodriguez M., Vila-Jato J.L., and Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J. Contr. Rel. 55 (1998) 67-77
17. Rosca I.D., Watari F., and Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J. Contr. Rel. 99 (2004) 271-280
18. Ruan G., Feng S.S., and Li Q.T. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J. Contr. Rel. 84 (2002) 151-160
19. Siveke J.T., and Folwaczny C. Medical approaches and future options in chronic active ulcerative colitis. Int. J. Colorectal Dis. 19 (2004) 297-307
20. Teixeira H., Dubernet C., Puisieux F., Benita S., and Couvreur P. Submicron cationic emulsions as a new delivery system for oligonucleotides. Pharm. Res. 16 (1999) 30-36
21. Törkvist L., Thorlacius H., Sjoqvist U., Bohman L., Lapidus A., Flood L., Agren B., Raud J., and Lofberg R. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol. Ther. 13 (1999) 1323-1328